Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 27, 2013
Medicyte has signed a licensing agreement for the rights to use Lentiviral vector technology from Life Technologies to develop and market next generation, cell-based upcyte® cell products to the biopharma and academic research markets.
read more
Wednesday, March 27, 2013
Aptuit announces that it offers fast screenings of synaptic activity on hippocampal slices for clients who are focused on the central nervous system (CNS) therapeutic area.
read more
SNBL USA, the experts in primate research, has entered into a consulting agreement with Dr. Pritam Sahota of Global ToxPath, LLC. Sahota is a recognized industry leader in toxicologic pathology evaluations within the framework of pharmaceutical ...
read more
Specialist in early genotoxicity screening and mechanistic follow-up, Gentronix, is pleased to announce the findings of new research published by GlaxoSmithKline (GSK) on the miniaturisation and automation of BlueScreen™ HC; a proprietary assay ...
read more
The Almac biocatalysis group has secured a prestigious BBSRC (Biotechnology and Biological Sciences Research Council) programme with UCL focused specifically on metagenomics and novel enzyme discovery. The R&D work concerned is set to be carried out ...
read more
BioDuro, A PPD® Company, today announced it has opened a new state-of-the-art laboratory in Shanghai, strengthening its ability to provide biopharmaceutical clients an extensive range of customized drug discovery services in Asia Pacific. The new lab...
read more
Cobra Biologics Ltd, the international clinical and commercial manufacturer of biologics and pharmaceuticals and Recopharma, a biotechnology company developing ophthalmic products, today announce an agreement to supply a human Fc fusion protein using...
read more
The U.S. regulatory landscape has changed dramatically in 10 years. In 2003, the FDA finally resolved legal hurdles to the 505(b)(2) approval pathway, making it a practical alternative route for drug development. The same year, Ken Phelps and Ruth ...
read more
MPI Research, the largest single-site preclinical/early clinical contract research organization (CRO) globally, is pleased to announce a strategic partnership with inviCRO and 3D Imaging to unite world-class molecular imaging, radiochemistry, and ...
read more
The University of South Florida College of Pharmacy and CoreRx, Inc., a research-based drug development firm, received a $200,000 award from the Florida High Tech Corridor to bolster the training needed to prepare students for innovation and ...
read more
Frontage Laboratories announces two senior appointments to lead its clinical services efforts. George Laskaris has been named Senior Director, Frontage Biometrics Services, bringing more than 20 years of programming, statistical and data management ...
read more
Intertek, the leading quality solutions provider to industries worldwide, announces that it has acquired Melbourn Scientific Ltd (“Melbourn”), a leading provider of analysis and development services for the pharmaceutical, biopharmaceutical, ...
read more
Catalent Pharma Solutions, a leading supplier of inhalation drug development, delivery and supply capabilities, today announced that it has entered into a contract with Biota Pharmaceuticals, Inc. (“Biota”), to develop and provide filling and ...
read more
Evotec AG today announced that its research alliance with Boehringer Ingelheim has reached a milestone in June triggering revenues of EUR 1.5 m to Evotec. The milestone was for the transition of a pain molecule into pre-clinical development.
read more
Last month in Germany, 40 experts in metabolism and environmental degradation met in the first forum of its kind to share research findings, discuss best practices, and debate the use of this data for the current and future environmental and human ...
read more